微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1.77% | -74.53% | 73.53% | 30/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 1.02% | -76.44% | 229.03% | 29/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 0.31% | -85.51% | -92.11% | 32/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 3.93% | -84.08% | -43.45% | 29/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 6.95% | -79.76% | 60.51% | 19/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 4.33% | -84.33% | 102.34% | 19/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 2.14% | -82.34% | -91.33% | 20/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 24.68% | 19.05% | -28.11% | 5/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 34.33% | 49.52% | 24.2% | 2/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 27.64% | 122.54% | 128.05% | 2/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 12.12% | 74.89% | -41.53% | 3/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 20.73% | 21.16% | -9.71% | 12/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 22.96% | 11.89% | 84.86% | 3/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 12.42% | 11.69% | 79.22% | 10/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 6.93% | 3976.47% | -59.5% | 7/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 17.11% | 141.67% | -16.62% | 19/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 20.52% | 124.75% | 84.53% | 5/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 11.12% | 88.47% | 6441.18% | 5/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 0.17% | -91.28% | -97.6% | 18/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 7.08% | -46.32% | -22.45% | 32/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 9.13% | -23.15% | 54.75% | 15/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 5.9% | -26.16% | 202.56% | 11/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 1.95% | -27.24% | -85.22% | 14/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 13.19% | 30.98% | 11.03% | 19/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 11.88% | 0.68% | 48.69% | 9/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 7.99% | -5.56% | 198.13% | 8/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 2.68% | -1.83% | -73.39% | 8/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 10.07% | -21.14% | -14.66% | 19/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 11.8% | 17.3% | 39.48% | 9/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 8.46% | 16.53% | 209.89% | 8/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 2.73% | 10.53% | -78.62% | 8/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 12.77% | -35.28% | 26.94% | 16/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 10.06% | -34.38% | 38.57% | 7/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 7.26% | -36.87% | 193.93% | 10/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 2.47% | -29.02% | -87.48% | 7/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 19.73% | 7.11% | 28.7% | 8/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 15.33% | 9.11% | 33.3% | 4/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 11.5% | 15% | 230.46% | 1/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 3.48% | 6.42% | -81.11% | 7/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |